Myelodysplastic Syndromes Clinical Trials in Baltimore

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
  • Myelodysplastic Syndromes
  • SY-1425 + Azacitidine
  • SY-1425 Matched Placebo + Azacitidine
  • Tucson, Arizona
  • +47 more
2022-01-12
Jan 12, 2022
A
Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +22 more
2021-12-05
Dec 5, 2021
G
Recruiting
  • Myelodysplastic Syndromes
  • Birmingham, Alabama
  • +143 more
2021-12-17
Dec 17, 2021
C
Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Donor Search Prognosis Score
  • Duarte, California
  • +51 more
2021-12-01
Dec 1, 2021
M
Recruiting
  • Myelodysplastic Syndromes
  • Miami, Florida
  • +5 more
2021-11-10
Nov 10, 2021
A
Completed
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • Duarte, California
  • +95 more
2021-09-01
Sep 1, 2021
I
Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • +3 more
  • Birmingham, Alabama
  • +26 more
2021-08-17
Aug 17, 2021
O
Completed
  • Myelodysplastic Syndromes
  • Oral rigosertib
  • Stanford, California
  • +13 more
2021-06-15
Jun 15, 2021
C
Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    2021-03-30
    Mar 30, 2021
    G
    Completed
    • Myelodysplastic Syndromes
    • anti-thymocyte globulin
    • Washington, District of Columbia
    • +27 more
    2021-01-24
    Jan 24, 2021
    A
    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Anniston, Alabama
    • +81 more
    2021-01-05
    Jan 5, 2021
    O
    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • rigosertib sodium
    • Stanford, California
    • +34 more
    2020-06-29
    Jun 29, 2020
    O
    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • ON 01910.Na
    • Scottsdale, Arizona
    • +86 more
    2020-06-29
    Jun 29, 2020
    U
    Completed
    • Leukemia
    • +3 more
    • daclizumab
    • +4 more
    • Baltimore, Maryland
      Marlene & Stewart Greenebaum Cancer Center, University of Maryla
    2019-10-31
    Oct 31, 2019
    U
    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • bevacizumab
    • +2 more
    • Atlanta, Georgia
    • +2 more
    2019-10-15
    Oct 15, 2019
    U
    Completed
    • Leukemia
    • +3 more
    • filgrastim
    • +3 more
    • Baltimore, Maryland
      Marlene & Stewart Greenebaum Cancer Center, University of Maryla
    2019-10-15
    Oct 15, 2019
    U
    Completed
    • Anemia
    • +5 more
    • anti-thymocyte globulin
    • +6 more
    • Baltimore, Maryland
      Marlene & Stewart Greenebaum Cancer Center, University of Maryla
    2019-10-15
    Oct 15, 2019
    U
    Completed
    • Leukemia
    • +3 more
    • anti-thymocyte globulin
    • +5 more
    • Baltimore, Maryland
      Marlene & Stewart Greenebaum Cancer Center, University of Maryla
    2019-10-15
    Oct 15, 2019
    S
    Terminated
    • Myelodysplastic Syndromes
    • K562/GM-CSF cell vaccine
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    2018-10-18
    Oct 18, 2018